As shown in Figure 12f, the anticancer mechanisms of LNE in breast cancer are primarily associated with the PI3K-Akt signaling pathway, EGFR tyrosine kinase inhibitor resistance, TNF signaling pathway, and HIF-1 signaling pathway. Here, AKT1 is linked to breast cancer.